Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 190 | 630 | 110 | 180 | 190 |
| Marketable Securities | 2,090 | 2,440 | 3,340 | 3,950 | 2,090 |
| Other current assets | 80 | 40 | 70 | 100 | 80 |
| TOTAL | $2,360 | $3,110 | $3,520 | $4,230 | $2,360 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 1,307 | 1,217 | 1,087 | 927 | 1,307 |
| TOTAL | $1,307 | $1,217 | $1,087 | $927 | $1,307 |
| Total Assets | $3,700 | $4,380 | $4,670 | $5,210 | $3,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 110 | 90 | 140 | 60 | 110 |
| Accrued Expenses | 190 | 320 | 220 | 280 | 190 |
| Other current liabilities | 40 | 8 | 20 | 30 | 40 |
| TOTAL | $350 | $420 | $390 | $390 | $350 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 90 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 90 | 0 | 90 | 90 | 90 |
| TOTAL | $90 | $90 | $90 | $90 | $90 |
| Total Liabilities | $440 | $510 | $480 | $480 | $440 |
| Shareholders' Equity | |||||
| Common Shares | 130 | 130 | 130 | 130 | 130 |
| Retained earnings | -14,290 | -13,610 | -13,120 | -12,570 | -14,290 |
| Other shareholders' equity | 0 | 0 | 0 | 10 | 0 |
| TOTAL | $3,250 | $3,860 | $4,180 | $4,730 | $3,250 |
| Total Liabilities And Equity | $3,690 | $4,370 | $4,660 | $5,210 | $3,690 |